These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29335258)

  • 1. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells.
    Ferdinand JR; Richard AC; Meylan F; Al-Shamkhani A; Siegel RM
    J Immunol; 2018 Feb; 200(4):1360-1369. PubMed ID: 29335258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator.
    Richard AC; Ferdinand JR; Meylan F; Hayes ET; Gabay O; Siegel RM
    J Leukoc Biol; 2015 Sep; 98(3):333-45. PubMed ID: 26188076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.
    Meylan F; Hawley ET; Barron L; Barlow JL; Penumetcha P; Pelletier M; Sciumè G; Richard AC; Hayes ET; Gomez-Rodriguez J; Chen X; Paul WE; Wynn TA; McKenzie AN; Siegel RM
    Mucosal Immunol; 2014 Jul; 7(4):958-68. PubMed ID: 24368564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling.
    Herro R; Miki H; Sethi GS; Mills D; Mehta AK; Nguyen XX; Feghali-Bostwick C; Miller M; Broide DH; Soloff R; Croft M
    J Immunol; 2020 Nov; 205(9):2414-2422. PubMed ID: 32958689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
    Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
    Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers.
    Yu X; Pappu R; Ramirez-Carrozzi V; Ota N; Caplazi P; Zhang J; Yan D; Xu M; Lee WP; Grogan JL
    Mucosal Immunol; 2014 May; 7(3):730-40. PubMed ID: 24220298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
    Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
    Front Immunol; 2019; 10():1624. PubMed ID: 31379829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
    Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
    Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
    Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble TL1A is sufficient for activation of death receptor 3.
    Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
    FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
    Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
    Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.
    Shih DQ; Barrett R; Zhang X; Yeager N; Koon HW; Phaosawasdi P; Song Y; Ko B; Wong MH; Michelsen KS; Martins G; Pothoulakis C; Targan SR
    PLoS One; 2011 Jan; 6(1):e16090. PubMed ID: 21264313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.